BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 26579545)

  • 1. Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
    Subhash VV; Yeo MS; Tan WL; Yong WP
    J Immunol Res; 2015; 2015():308574. PubMed ID: 26579545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of gastric cancer: Past, future perspective and challenges.
    Xie J; Fu L; Jin L
    Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell therapy in advanced gastric cancer: a promising new hope?
    Tewari M; Sahai S; Mishra RR; Shukla SK; Shukla HS
    Surg Oncol; 2012 Sep; 21(3):164-71. PubMed ID: 22521560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
    Dolcetti R; De Re V; Canzonieri V
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29844297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in gastric cancer.
    Matsueda S; Graham DY
    World J Gastroenterol; 2014 Feb; 20(7):1657-66. PubMed ID: 24587645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological battlefield in gastric cancer and role of immunotherapies.
    Wang M; Busuttil RA; Pattison S; Neeson PJ; Boussioutas A
    World J Gastroenterol; 2016 Jul; 22(28):6373-84. PubMed ID: 27605873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogenic dendritic cell and tumor cell fused vaccine for targeted imaging and enhanced immunotherapeutic efficacy of gastric cancer.
    Li C; Liang S; Zhang C; Liu Y; Yang M; Zhang J; Zhi X; Pan F; Cui D
    Biomaterials; 2015 Jun; 54():177-87. PubMed ID: 25907051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentials.
    Abdel-Rahman O
    Crit Rev Oncol Hematol; 2016 Jan; 97():65-71. PubMed ID: 26321371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of therapeutic approaches to gastric cancer.
    Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D
    J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for metastatic colorectal cancer: present status and new options.
    Ellebaek E; Andersen MH; Svane IM; Straten PT
    Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
    Alsina M; Moehler M; Hierro C; Guardeño R; Tabernero J
    Target Oncol; 2016 Aug; 11(4):469-77. PubMed ID: 26880697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines: an update with special focus on ganglioside antigens.
    Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
    Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment.
    Vasaturo A; Verdoes M; de Vries J; Torensma R; Figdor CG
    Immunobiology; 2015 Feb; 220(2):243-8. PubMed ID: 25466585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Therapy.
    Lievense L; Aerts J; Hegmans J
    Adv Exp Med Biol; 2016; 893():59-90. PubMed ID: 26667339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injecting Hope--A Review of Breast Cancer Vaccines.
    Mittendorf EA; Peoples GE
    Oncology (Williston Park); 2016 May; 30(5):475-81, 485. PubMed ID: 27188680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model.
    Bourquin C; von der Borch P; Zoglmeier C; Anz D; Sandholzer N; Suhartha N; Wurzenberger C; Denzel A; Kammerer R; Zimmermann W; Endres S
    J Immunol; 2010 Aug; 185(4):2580-8. PubMed ID: 20644173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer and the epoch of immunotherapy approaches.
    Niccolai E; Taddei A; Prisco D; Amedei A
    World J Gastroenterol; 2015 May; 21(19):5778-93. PubMed ID: 26019442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the immune system for the treatment of breast cancer.
    Jiang X
    J Zhejiang Univ Sci B; 2014 Jan; 15(1):1-15. PubMed ID: 24390741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of lung cancer: an update.
    Rüttinger D; Winter H; van den Engel NK; Hatz RA; Schlemmer M; Pohla H; Grützner S; Schendel DJ; Fox BA; Jauch KW
    Onkologie; 2006 Feb; 29(1-2):33-8. PubMed ID: 16514254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.